Specialized support for complex, high-stakes cell and gene therapies from approval through long-term follow-up
Cell and gene therapies (CGT) are reshaping what’s possible in rare disease care. As many rare diseases are genetic in origin, innovation in CGT has accelerated rapidly, bringing therapies with the potential for durable, and in some cases transformative, impact.
But these therapies also introduce unprecedented complexity. High product value, narrow treatment windows, intensive coordination, and long-term follow-up requirements mean success depends on more than distribution alone.
As early successes in CGT reshape rare disease care, PANTHERx is ready to be your trusted partner, delivering precision, reliability, and innovation to bring these groundbreaking advanced therapies to treatment centers and patients nationwide.
For PANTHERx, readiness means more than distribution. It means actively removing barriers across access, logistics, and coordination while safeguarding product integrity and the treatment journey.
See how PANTHERx supports CGT patients and life-changing therapies
Our rare legacy led us to CGT
Since the founding of PANTHERx in 2011, we’ve consistently proven our ability to deliver value while managing complexity, customizing our care, service, and distribution models to align with the unique needs of our patients, prescribers, and manufacturer partners.
We have supported first-to-market novel therapies, including the innovative small interfering RNA (siRNA) therapies, cold chain products requiring precise handling, and high-profile shipments exceeding traditional specialty pharmacy dollar values.
This experience managing therapies with little margin for error is what uniquely prepared us to support the complexity and stakes of cell and gene therapies.
With the CGT pipeline heavily concentrated in orphan diseases, we’re investing in capabilities anchored by RxARECONCIERGE®, a customizable model that simplifies access, logistics, and coordination for treatment centers and the patients they serve.
RxARECONCIERGE®
Care precisely tuned to the requirements of CGT
RxARECONCIERGE® is our customizable care and coordination model designed specifically to support the unique demands of cell and gene therapies. It brings together access expertise, logistical precision, and hands‑on support for treatment centers, prescribers, and patients.
RxARECONCIERGE®
Care precisely tuned to the requirements of CGT
- Dedicated, specialized access and reimbursement support services
- Ultra-low-temperature handling and storage
- Flexible fulfillment models for time sensitive and scalable therapy needs
- Coordinated guidance and support for treatment centers and their patients across every step of the CGT journey
- Real‑time shipment monitoring
- Long-term follow-up that supports required reporting and real-world monitoring
- Actionable insights that identify barriers to strengthen performance
RxARECONCIERGE is how we transform precision science into access, and access into real-world outcomes.
Ready to learn more?
Connect with the PANTHERx team to explore how our cell and gene therapy pharmacy capabilities can support your program and the patients you serve.
PDUFA to Patient: A Guide to Rare Disease Launch Success
This guide outlines the three launch levers that strongly influence success in rare disease markets, and how manufacturers can activate them to accelerate access and optimize patient outcomes.
Launch experts at PANTHERx Rare